Form D · Manufacturing

Immunocept Medical Products, LLC

Denver, CO · CIK 0001701236

Offering snapshot reported Aug 3, 2017 · SEC filing

Reported sold
$530K
Offering amount: $530K
Investors reported
6
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Apr 24, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$265K$530KMay 4, 2017: $250,000.00May 4, 2017Aug 3, 2017: $530,000.00Aug 3, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$250,000 → $530,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 3, 2017Amendment$530,000$280,000vs May 4, 20176SEC filing
May 4, 2017Initial$250,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-286009

Source: Form D, filed Aug 3, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Chris Jaynes Executive
James Matson Executive

Issuer details

Industry: Manufacturing (See others in industry)

Address:
1800 Lawrence St. Suite 306
Denver, CO, 80202